Ovarian cancer is second most common in gynecologic malignancies, but is most common cause of death in gynecologic malignancies. Almost were advance stage at first visit and delay hospitalization due to late symptoms. Patients had poor outcome. treatment and high rate recurrent and dead. Poor quality of life due to many times surgery and many chemotherapy regimen. Ovarian Cancer, Neoadjuvant Chemotherapy, Primary Surgery, Complete Remission, Survival, Propensity Score
Conditions
Interventions
Patients with neoadjuvant chemotherapy in advance stage ovarian cancer, peritoneal cancer, fallopian tube cancer.,Patients with surgery in advance stage ovarian cancer, peritoneal cancer, fallopian tu
Treatment,Treatment
chemotherapy patients., surgery patients.
Sponsors
Surin cancer center
Obstetrics and gynecology
Eligibility
Sex/Gender
Female
Age
5 Years to 99 Years
Inclusion criteria
Inclusion criteria: Advance stage ostage III-IV ovarian cancer, fallopian tube cancer and peritoneal cancer who underwent treatment at Oncologic gynecology unit, Surin hospital of Thailand from 1 January 2011 to 30 April 2021 and couldn follow survival to 30 November 2021.varian cancer, fallopian tube cancer, peritoneal cancer stage III-IV
Exclusion criteria
Exclusion criteria: inoperable in primary surgery group and unfit in NACT group
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Complete remission , partial or stable , dead 1 month after last cycle chemotherapy evaluate by physical exam , pelvic exam and CT whloe abdomen after adjuvant chemotherapy 6 cycle | — |
Secondary
| Measure | Time frame |
|---|---|
| survival 10 year time between diagnosis date to dead or 30 november 2021 (alive) | — |
Countries
Thailand
Contacts
Public Contactsunaree pitchaiprasert
Surin hospital
Outcome results
None listed